Lantheus: Lantheus Holdings completes Evergreen Theragnostics acquisition
By acquiring the radiopharmaceutical specialist, Lantheus Holdings will gain access to Evergreen's radioligand manufacturing capacity, as well as its CDMO division
Read full article »
CEO
Brian Markison
Lantheus is a Massachusetts-based holding company that owns businesses that develop and commercialize diagnostic and therapeutic products to treat cancer and heart diseases.
Read more